E. Taranchon

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Ken A. Olaussen, Ariane Dunant, Pierre Fouret et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Molecular Biology, Oncology +16

Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes

Michel Kalamarides, Anat Stemmer‐Rachamimov, Michiko Niwa‐Kawakita et al. · Oncogene · 2011 · 158 citations

Medicine, Cancer Biology, Cell Biology +8

Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Adriana Handra‐Luca, Juana Hernández, Giannis Mountzios et al. · Clinical Cancer Research · 2007 · 137 citations · Full text

Medicine, Cancer Biology, Oncology +13

Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites

Carlos Gomez‐Roca, Christophe M. Raynaud, Frédérique Penault‐Llorca et al. · Journal of Thoracic Oncology · 2009 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +16

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials

Rosa Conforti, Thomas Boulet, Gorana Tomasic et al. · Annals of Oncology · 2007 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17